Interpace, Rutgers, Mass General Sign Deal for Pancreatic Cyst Risk Assessment Biomarker
Interpace said that the novel monoclonal antibody, Das-1, will provide additional data regarding pancreatic cancer risk to guide personalized patient management.
Johns Hopkins Team Develops Test to Guide Pancreatic Cyst Treatment
The researchers have developed CompCyst, which uses clinical features, imaging, and molecular data, to guide pancreatic cysts treatment approaches.
Researchers combined a new and established biomarker to detect nearly 70 percent of pancreatic cancers with a less than 5 percent false-positive rate.
Pancreatic Cancer Sequencing Test From University of Pittsburgh Team Helps Identify Cancerous Cysts
The seven-gene NGS-based test is available for patients who are found to have pancreatic cysts, and can help physicians decide whether to remove them.